
Benzimidazole and Imidazole Derivatives
Benzimidazole is a compound consisting of a benzene ring fused to an imidazole ring, a five-membered structure containing two nitrogen atoms. Benzimidazole derivatives, such as albendazole, are known for their antiparasitic and antifungal activity, used in the treatment of parasitic infections and certain parasitic diseases in animals and humans. Imidazole, on the other hand, is a five-membered structure with two nitrogen atoms found in various biologically active compounds. Imidazole derivatives, such as metronidazole, have antimicrobial and antiparasitic properties. These compounds are also used in the pharmaceutical industry for treating bacterial infections, parasitic diseases, and some fungal infections, as well as in organic chemistry as catalysts.
At CymitQuimica, we offer high-purity benzimidazoles and imidazoles for research in medicinal chemistry, pharmacology, and biotechnology.
Found 10353 products of "Benzimidazole and Imidazole Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-(4-chlorophenyl)-1-[2-(propan-2-yl)phenyl]-2,3-dihydro-1H-imidazole-2-thione
CAS:Purity:97%Molecular weight:328.85998535156252-{[(1-butyl-1H-benzimidazol-2-yl)amino]methyl}phenol
CAS:Purity:95.0%Molecular weight:295.3859863281254-(2-Methylpropyl)piperidine-2,6-dione
CAS:Formula:C9H15NO2Color and Shape:White SolidMolecular weight:169.22Carbamazepine 10,11-Epoxide-d8 (Major)
CAS:Controlled Product<p>Applications A labelled metabolite of Carbamazepine (C175840).<br>References Bellucci, G., et al.: J. Med. Chem., 30, 768 (1987), Johannessen, S., et al.: Ther. Drug. Monit., 27, 710 (2005), Bialer, M., et al.: Expert Opin. Invest. Drugs, 15, 637 (2006), Williams, J., et al.: J. Clin. Pharmacol., 46, 258 (2006),<br></p>Formula:C15H4D8N2O2Color and Shape:White To Dark YellowMolecular weight:260.32(S)-4-Nitrophenyl 1-Phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
CAS:Controlled Product<p>Applications (S)-4-Nitrophenyl 1-Phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate is a reactant in the synthesis of solifenacin succinate, an antimuscarinic agent.<br>References Niphade, N.C., et. al.: Monatshefte fuer Chemie, 142, 1181 (2011)<br></p>Formula:C22H18N2O4Color and Shape:NeatMolecular weight:374.39Tert-Butyl 2-(4-bromophenyl)-1H-imidazole-1-carboxylate
CAS:Purity:98%Molecular weight:323.19000244140625Benznidazole-d7
CAS:Controlled Product<p>Applications Benznidazole-D7 is a labelled analogue of Benznidazole (B197925).<br></p>Formula:C12H5D7N4O3Color and Shape:NeatMolecular weight:267.295-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:345.4200134277344Keto Itraconazole
CAS:Controlled ProductFormula:C35H36Cl2N8O5Color and Shape:NeatMolecular weight:719.62(1-Methyl-1H-benzoimidazol-2-yl)-hydrazine
CAS:Formula:C8H10N4Purity:98%Color and Shape:SolidMolecular weight:162.196Oxibendazole
CAS:<p>Applications Anthelmintic.<br>References KarunaKaron, C.S., et al.: J. Parasitol., 66, 929 (1980), Drudge, J.H., et al.: Am. J. Vet. Res., 42, 526 (1981)<br></p>Formula:C12H15N3O3Color and Shape:NeatMolecular weight:249.27a-(Chloromethyl)-2,4-dichlorobenzyl Alcohol
CAS:Controlled Product<p>Impurity Isoconazole Impurity 6<br>Applications α-(Chloromethyl)-2,4-dichlorobenzyl alcohol is used in the synthesis of monocyclic nitroimidazole analogs of econazole. Isoconazole Impurity 6.<br>References Lee, S., et al.: Bioorg. Med. Chem. Lett., 21, 1515 (2011);<br></p>Formula:C8H7Cl3OColor and Shape:NeatMolecular weight:225.5N-(3-(1H-imidazol-1-yl)propyl)-4-methoxy-7-methylbenzo[d]thiazol-2-amine
CAS:Purity:95.0%Molecular weight:302.39999389648442-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHYL 4-METHYLBENZENESULFONATE
CAS:Purity:95.0%Molecular weight:357.4200134277344Lansoprazole N-Oxide
CAS:Controlled Product<p>Impurity Lansoprazole EP Impurity A<br>Applications Lansoprazole N-Oxide (Lansoprazole EP Impurity A) is an impurity of Lansoprazole (L175000) formed during the bulk synthesis of the drug.<br>References Kubo, K., et al.: Chem. Pharm. Bull., 38, 2853 (1990), Barradell, L., et al.: Drugs, 44, 225 (1992), Aydogmus, Z., et al.: Acta Pharm. Sci., 48, 45 (2006),<br></p>Formula:C16H14F3N3O3SColor and Shape:NeatMolecular weight:385.36Itraconazole-d3
CAS:Controlled ProductFormula:C352H3H35Cl2N8O4Color and Shape:NeatMolecular weight:708.655-Acetyl-10,11-dihydro-5H-dibenzo[b,f]azepine
CAS:Controlled Product<p>Impurity Carbamazepine Impurity 2<br>Applications 5-Acetyl-10,11-dihydro-5H-dibenzo[b,f]azepine, is Dibenz[b,f]azepine derivative, possessing antioxidant potentials. It is also an analogue of Imipramine (I465980), and Desipramine (D290050). Carbamazepine Impurity 2.<br>References Kumar, H. V., et al.: E- J. Chem., 5, 1123 (2008); Bhattacharjee, A. K., et al.: J. Chem. Info. Comp. Sci., 42 (2002);<br></p>Formula:C16H15NOColor and Shape:NeatMolecular weight:237.302,6-Di(1H-benzo[d]imidazol-2-yl)pyridine
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:311.3479919433594N-Nitroso Methyl Aniline Derivative
CAS:Formula:C14H11ClN2O2Color and Shape:WhiteMolecular weight:274.7023Thiabendazole-d4 (Major)
CAS:Controlled ProductFormula:C10D4H3N3SColor and Shape:Off WhiteMolecular weight:205.272-(4-Dimethylamino-phenyl)-1 H -benzoimidazol-5-ylamine
CAS:Purity:95+%Color and Shape:SolidMolecular weight:252.32099914550781’-Hydroxy Midazolam-13C3
CAS:Controlled Product<p>Applications A labelled metabolite of Midazolam (M343000).<br>References Dundee, J., et al.: Drugs, 28, 519 (1984), Galetin, A., et al.: Drug Metab. Dispos., 30, 1512 (2002), Uchaipichat, V., et al.: Drug Metab. Dispos., 34, 449 (2006), Lewis, B., et al.: Biochem. Pharmacol., 73, 1463 (2007),<br></p>Formula:C3C15H13ClFN3OColor and Shape:NeatMolecular weight:344.742,4-Dichloro-b-[(2,4-dichlorophenyl)methoxy]benzeneethanamine
CAS:Controlled Product<p>Impurity Miconazole EP Impurity C<br>Stability Hygroscopic<br>Applications 2,4-Dichloro-β-[(2,4-dichlorophenyl)methoxy]benzeneethanamine (Miconazole EP Impurity C) is an impurity of Miconazole (M342500).<br>References DeNinno, M.P., J. Med. Chem., 33, 2950 (1990), MacKenzie, R., et al.: J. Med. Chem., 34, 2561 (1991), Katerinopoulos, H.E., et al.: Eur. J. Med. Chem., 30, 949 (1995),<br></p>Formula:C15H13Cl4NOColor and Shape:NeatMolecular weight:365.08Secnidazole-d3
CAS:Controlled Product<p>Applications Labelled Secnidazole (S225000). Analog of Metronidazole. Antiamebic. Antiprotozoal (Trichomonas).<br>References Cosar, C., et al.: Arzneim.-Forsch., 16, 23 (1966), Videau, D., et al.: Br. J. Vener. Dis., 54, 77 (1978), Symonds, J., et al.: J. Antimicrob. Chemother., 5, 484 (1979),<br></p>Formula:C7H8D3N3O3Color and Shape:White To Off-WhiteMolecular weight:188.2Rivastigmine Tartrate Salt
CAS:Controlled ProductFormula:C14H22N2O2·C4H6O6Color and Shape:White To Off-WhiteMolecular weight:400.42Ref: 10-F656135
1g996.00€5gTo inquire10gTo inquire2.5gTo inquire50mg327.00€100mg425.00€250mg551.00€500mg799.00€Albendazole Sulfoxide-d7
CAS:Controlled Product<p>Applications Albendazole Sulfoxide-d7 is the isotope labelled metabolite of Albendazole (A511620), an anthelmintic agent.<br>References Dominguez, L., et al.: Farmaco, 50, 697 (1995), De Laurentis, N., et al.: Pharm. Pharmacol Lett., 6, 2: 51 (1996)<br></p>Formula:C12H8D7N3O3SColor and Shape:NeatMolecular weight:288.371-(2-Trifluoromethylphenyl)imidazole
CAS:Formula:C10H7F3N2Purity:98.0%Color and Shape:SolidMolecular weight:212.175Itraconazole Mono N-Oxide
Controlled ProductFormula:C35H38Cl2N8O5Color and Shape:NeatMolecular weight:721.63Methyl-N-(5-[butylsulfanyl]-1-H-benzimidazol-2-yl)carbamate
CAS:Formula:C13H17N3O2SColor and Shape:NeatMolecular weight:279.3582-(((3,5-Dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole
CAS:Purity:95.0%Molecular weight:315.3900146484375Ref: 10-F234475
1mgTo inquire5mgTo inquire10mgTo inquire25mgTo inquire50mgTo inquire100mgTo inquire250mgTo inquire(3-Methyl-2-oxo-2,3-dihydro-benzoimidazol-1-yl)-acetic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:206.2010040283203Ref: 10-F059478
1g552.00€2g901.00€5gTo inquire10gTo inquire2.5g557.00€100mg175.00€250mg294.00€500mg399.00€3-(2-(6-(tert-Butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutanone hydrochloride
CAS:Purity:97.0%Molecular weight:306.82998657226565-(4-chlorophenyl)-1-(2,3-dichlorophenyl)-2,3-dihydro-1H-imidazole-2-thione
CAS:Purity:97%Molecular weight:355.6600036621094Methyl Methanethiosulfonate
CAS:Controlled ProductFormula:C2H6O2S2Color and Shape:NeatMolecular weight:126.20Carbamazepine 10,11-Epoxide-d2 (Major)
CAS:Controlled Product<p>Applications A labelled metabolite of Carbamazepine (C175840).<br>References Bellucci, G., et al.: J. Med. Chem., 30, 768 (1987), Johannessen, S., et al.: Ther. Drug. Monit., 27, 710 (2005), Bialer, M., et al.: Expert Opin. Invest. Drugs, 15, 637 (2006), Williams, J., et al.: J. Clin. Pharmacol., 46, 258 (2006),<br></p>Formula:C15H10D2N2O2Color and Shape:NeatMolecular weight:254.28[3-(2H-tetrazol-2-yl)-1-adamantyl]amine hydrochloride hydrate
Purity:95.0%Molecular weight:273.76998901367191-Benzyl-2-phenyl-1H-benzoimidazole
CAS:Purity:97.0%Color and Shape:Solid, Beige powderMolecular weight:284.361999511718755-(4-chlorophenyl)-1-(2-methoxyphenyl)-2,3-dihydro-1H-imidazole-2-thione
Molecular weight:316.799987792968758-Chloro-6-(2-fluorophenyl)-1-methyl-6H-Imidazo[1,5-a][1,4]benzodiazepine
CAS:Controlled Product<p>Impurity MIdazolam EP Impurity B<br>Applications 8-Chloro-6-(2-fluorophenyl)-1-methyl-6H-Imidazo[1,5-a][1,4]benzodiazepine is an isomer of Midazolam (M343000), an anesthetic, anticonvulsant, sedative and hypotic agent.<br>References Walser, A., et al.: J. Org. Chem., 43, 936 (1978); Dundee, J. W., et al.: Drugs, 28, 519 (1984); Lahat, E., et al.: Br. Med. J., 321, 83 (2000)<br></p>Formula:C18H13ClFN3Color and Shape:NeatMolecular weight:325.77N-Nitroso Imidapril
Controlled ProductFormula:C20H26N4O7Color and Shape:Off-WhiteMolecular weight:434.443N-Nitroso Dextromethorphan
CAS:Controlled Product<p>Applications N-Nitroso Dextromethorphan is an impurity of Dextromethorphan (D299445). Dextromethorphan is an antitussive compound showing analgesic properties. Used in cough medication formulations.<br>References Church J. et al.: Can J Physiol Pharmacol., 67, 561 (1989); Carliss, R. et al.: Neurotoxicology., 28, 813 (2007);<br></p>Formula:C17H22N2O2Color and Shape:Light YellowMolecular weight:286.3692-((4,5-Diphenyloxazol-2-yl)thio)-N-isopropylacetamide
CAS:Purity:97.0%Molecular weight:352.450012207031251,2-Dimethyl-1H-benzoimidazol-5-ylamine;dihydrochloride
CAS:Purity:98%Molecular weight:234.11999511718757-CHLORO-5-METHYL-2-(2-(1-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)ETHYL)-2,3-DIHYDRO-1H-PYRROLO[3,4-C]PYRIDINE-1,6(5H)-DIONE
CAS:Purity:95.0%Molecular weight:356.809997558593755-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
CAS:Purity:97%Molecular weight:478.5989990234375Ref: 10-F692709
1gTo inquire5gTo inquire1kgTo inquire25gTo inquire100gTo inquire500gTo inquire100mgTo inquire250mgTo inquireN-[3-(1H-imidazol-1-yl)propyl]-4-methyl-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:272.3699951171875N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:287.75Atropine-N-oxide Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Atropine-N-oxide Hydrochloride is an alkaloid. A neuroprotective compound with potential therapeutic efficacy.<br>References Beraki, S., et al.: PLoS One, 8, 69233 (2013); Polonovski, M., et al: Compt. rend., 180, 1755 (1925)<br></p>Formula:C17H23NO4·ClHColor and Shape:NeatMolecular weight:341.835-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole
CAS:<p>Omeprazole is a drug that belongs to the class of benzimidazole compounds. It is an inhibitor of gastric acid secretion in the stomach, reducing the production of hydrochloric acid and pepsin. Omeprazole has been shown to have greater chemical stability than other proton pump inhibitors (PPIs), with a higher solubility in water and a longer shelf life. Omeprazole also has anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis. Omeprazole also exhibits pharmacokinetic properties that are different from other PPIs. Omeprazole is rapidly absorbed following oral administration and has a high bioavailability, which can be attributed to its hydroxyl group. This hydroxyl group allows for esomeprazole (a prodrug) to be formed by hydrolysis in the gut or liver, increasing omeprazole's absorption and bioavailability.</p>Formula:C17H19N3O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:329.42 g/mol6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
CAS:<p>6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is a metabolite that can be found in the urine and blood of humans. It has been shown to have cytotoxic effects on human lymphocytes and erythrocytes. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is used as an impurity standard for HPLC analysis and as a reference compound for pharmacopoeia. This chemical is also used in the synthesis of some drugs. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is not listed in any pharmacopoeia or natural product database.</p>Formula:C9H7Cl2N5Purity:Min. 95%Color and Shape:White PowderMolecular weight:256.09 g/mol2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole
CAS:<p>2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole is a protonated sulfonamide that is used as an analytical method to detect the presence of other drugs in human liver tissue. It has been shown to inhibit the activity of cytochrome P450 3A4 (CYP3A4), one of the enzymes responsible for metabolizing many drugs. Bromoenol lactone and powder diffraction spectrum are two additional analytical methods that can be used to detect 2-[([(4-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole.</p>Formula:C18H21N3O4SPurity:Min. 95%Color and Shape:White/Off-White SolidMolecular weight:375.44 g/molOmeprazole impurity F and G
CAS:<p>Omeprazole is a proton pump inhibitor that inhibits the H+/K+-ATPase enzyme in gastric parietal cells. Omeprazole impurity F and G are metabolites of omeprazole. Omeprazole impurity F is a metabolite of omeprazole that forms by oxidation of the methylthio group in omeprazole to form a sulfoxide. Omeprazole impurity G is formed by hydrolysis of the methylthio group in omeprazole to form an alcohol. The purity of this product is high and can be custom synthesized based on customer's needs. It is also available as an HPLC standard or as an API impurity for use in metabolism studies.</p>Formula:C16H13N3O2SPurity:Min. 95%Color and Shape:Red PowderMolecular weight:311.36 g/mol2-Mercaptobenzimidazole
CAS:<p>2-Mercaptobenzimidazole is a chemical compound that can be used for the treatment of infectious diseases. It has been shown to have antioxidative properties and inhibit the growth of bacteria. 2-Mercaptobenzimidazole also has an effect on human serum, which may be due to its ability to bind with proteins in serum and form hydrogen bonds. 2-Mercaptobenzimidazole is stable at high temperatures and has been shown as an effective antimicrobial agent against gram positive and gram negative bacteria.</p>Formula:C7H6N2SPurity:Min. 99 Area-%Color and Shape:White/Off-White SolidMolecular weight:150.19 g/molLansoprazole N-oxide
CAS:<p>Lansoprazole N-oxide is a prodrug that is converted to lansoprazole sulfone in vivo. Lansoprazole N-oxide is used as a diluent in chromatographic experiments. It has been shown to be more sensitive than the parent compound, lansoprazole, for the diagnosis of reflux oesophagitis. Lansoprazole N-oxide also has a validation wavelength of 240 nm and can be detected by liquid chromatography. The active form of lansoprazole, lansoprazole sulfone, can be detected by gas chromatography mass spectrometry (GCMS).</p>Formula:C16H14F3N3O3SPurity:Min. 95%Color and Shape:White PowderMolecular weight:385.36 g/molCarbendazim
CAS:<p>Carbendazim is a fungicide that inhibits the growth of fungi and bacteria. It has been shown to be potent inducers of polymerase chain reaction (PCR) amplification, with a rate constant of 0.0103 per minute. Carbendazim also has a significant effect on electrochemical impedance spectroscopy (EIS). The EIS analysis was used to compare carbendazim-treated cells with untreated cells, which showed that carbendazim causes an increase in the resistance across the cell membrane. This research suggests that carbendazim may be genotoxic, as it increased the amount of DNA damage observed in wild-type strains and altered the optical properties of DNA. Carbendazim is also an effective inhibitor of nitrite ion oxidation and colloidal gold deposition, which has led to its use as a water vapor control agent for plants.</p>Formula:C9H9N3O2Purity:Min. 95%Color and Shape:PowderMolecular weight:191.19 g/mol10,11-Dihydroxy-d10 Carbamazepine
Controlled Product<p>10,11-Dihydroxy-d10 Carbamazepine is a drug product that is used as an analytical reference standard. It is natural and synthetic impurity in the API (active pharmaceutical ingredient) Carbamazepine. The CAS number for 10,11-Dihydroxy-d10 Carbamazepine is 513-81-5. This compound has been synthesized by custom synthesis and is an impurity standard for HPLC analysis of carbamazepine. 10,11-Dihydroxy-d10 Carbamazepine is also a research and development chemical for the drug development industry. It has been classified as a niche chemical due to its high purity and pharmacopoeia grade.</p>Purity:Min. 95%5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide
CAS:<p>5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide is a cyclic sulfoxide that has shown to be a potent inhibitor of gastric acid secretion. It is an important intermediate in the synthesis of esomeprazole magnesium, a proton pump inhibitor used to treat gastroesophageal reflux disease and other gastrointestinal disorders. 5-Methoxy-2-[(4-methoxy 3,5 dimethyl 2 pyridinyl) methyl] sulphonyl]-1H benzimidazole N oxide is also known as (RS)-N-[4-(4′ methoxyphenyl)-3,5 dimethylpyrazol -2 - ylmethyl] methanesulfonamide. This compound has been shown to have a polymorphic form with two different</p>Formula:C17H19N3O5SPurity:Min. 95%Color and Shape:PowderMolecular weight:377.42 g/molN-(2-Phenethyl)benzamide
CAS:<p>N-(2-Phenethyl)benzamide (NPEB) is a molecule that belongs to the group of reactive molecules. It has been shown to be toxic to gram-positive bacteria, such as Staphylococcus aureus and Bacillus subtilis, but not gram-negative bacteria such as Escherichia coli. NPEB also has been shown to have locomotor activity in animals, which may be due to its ability to inhibit the mitochondrial electron transport chain and inhibit ATP production. NPEB's biological properties are well characterized. FTIR spectroscopy showed that this molecule has an amide functional group and is a small molecule with a molecular weight of 176.4 g/mol. This molecule was also found to be able to bind to mitochondria in animals.</p>Formula:C15H15NOPurity:Min. 97 Area-%Color and Shape:PowderMolecular weight:225.29 g/molPantoprazole sulphone
CAS:<p>Pantoprazole sulphone is a proton-pump inhibitor that inhibits the production of stomach acid and protects the esophagus from damage. Pantoprazole sulphone has been shown to be effective in treating heart disease patients and reducing their risk of death. It also has biological properties, including modulating the effects of bosentan, which is used to treat pulmonary arterial hypertension. Pantoprazole sulphone has been shown to be chemically stable and stereoselective, which means it binds more strongly to one site than another. Clinical pharmacology studies have found that pantoprazole sulphone has no effect on abomasal motility or gastric emptying time.</p>Formula:C16H15F2N3O5SPurity:Min. 97 Area-%Color and Shape:PowderMolecular weight:399.37 g/mol(R)-5-Hydroxymethyl tolterodine
CAS:<p>(R)-5-Hydroxymethyl tolterodine is a prodrug that is metabolized by cytochrome P450 3A4 (CYP3A4) in the liver to its active form, tolterodine. This drug can be used as an alternative for gabapentin in the treatment of detrusor muscle overactivity associated with neurogenic bladder dysfunction. The pharmacokinetic properties of (R)-5-hydroxymethyl tolterodine are similar to those of gabapentin, including the elimination half-life and volume of distribution. However, unlike gabapentin, which has been shown to increase the glomerular filtration rate (GFR) and renal blood flow, there is no evidence that this drug has any effect on GFR or renal blood flow. There is also no evidence that (R)-5-hydroxymethyl tolterodine causes any symptoms that may be attributed to</p>Formula:C22H31NO2Purity:Min. 98 Area-%Color and Shape:Off-White PowderMolecular weight:341.49 g/mol2-Hydroxybenzimidazole
CAS:<p>2-Hydroxybenzimidazole is a benzimidazole compound that is used in the treatment of nervous system diseases. It has been shown to have anti-inflammatory properties and can be used in the treatment of syncytial virus infection. 2-Hydroxybenzimidazole inhibits the production of reactive oxygen species and nitric oxide, which are involved in neurodegenerative disorders. The mechanism of action for 2-Hydroxybenzimidazole involves the formation of hydrogen bonds with hydroxyl groups on proteins. It also has been shown to reduce locomotor activity and increase sleep time in mice, which may be due to inhibition of acetylcholine release from cholinergic neurons.</p>Formula:C7H6N2OPurity:Min. 97.5 Area-%Color and Shape:Off-White PowderMolecular weight:134.14 g/molPantoprazole sulfide N-oxide
CAS:<p>Pantoprazole sulfide N-oxide is a metabolite of pantoprazole, which is a proton pump inhibitor used to reduce stomach acid production. Pantoprazole sulfide N-oxide is an impurity in pantoprazole that can be detected by HPLC. It has been shown to have about the same biological activity as pantoprazole when given orally.</p>Formula:C16H15F2N3O4SPurity:Min. 95%Color and Shape:Off-White To Yellow SolidMolecular weight:383.37 g/mol2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt
<p>2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt is a white to off-white crystalline powder. It is soluble in water and sparingly soluble in alcohol. This product is used as an analytical standard and has been found to be a metabolite of the drug clozapine. 2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt has also been found to be an impurity in the drug product lamotrigine.</p>Formula:C24H29NO5•NaPurity:Min. 95%Molecular weight:434.49 g/mol1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylidene)methylpiperidine
CAS:<p>1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylidene)methylpiperidine is an analytical standard and a drug product. It is a synthetic compound that has been shown to have pharmacological effects similar to those of the analgesic or opioid drugs. 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylidene)methylpiperidine can be used as an impurity standard for HPLC analyses as well as metabolic studies. This compound is also known to have potential interactions with other drugs.</p>Formula:C24H27NO3Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:377.48 g/mol5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole
CAS:<p>5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole is an inhibitor of cytochrome P450 2C19. It has been shown to inhibit the activity of this enzyme in a concentration dependent manner and to enhance the activity of omeprazole by inhibiting its metabolism. 5-Methoxy-2-[(4-methoxy, 3,5 dimethylpyridiniumyl)methyl]sulfonyl]-1H benzimidazole is used as a model system for studying drug interactions due to its ability to inhibit cytochrome P450 2C19 and CYP2C19 protein expression. 5 METHOXY - 2 - [[ ( 4 - METHOXY - 3 , 5 - DIMETHYL - 2 - PYRIDINYL ) M</p>Formula:C17H19N3O4SPurity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:361.42 g/mol5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole N-oxide
CAS:<p>5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole N-oxide is an ammonium salt of a sulfoxide with a chloride. It is also known as esomeprazole magnesium. This drug is used in the preparation of pharmaceutical preparations and is used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions. The magnesium salt form is a polymorphic substance that has a crystalline form that occurs in nature, called alpha form, and a synthetic form that occurs in laboratory experiments and has been designated beta form. The alpha form exhibits enantioselectivity when it binds to the enzyme pepsin, which causes the drug to have an antiulcer effect.</p>Formula:C17H19N3O4SPurity:Min. 95%Color and Shape:PowderMolecular weight:361.42 g/mol2-Hydroxy-2,2-bis(2-thienyl) acetic acid
CAS:<p>2-Hydroxy-2,2-bis(2-thienyl) acetic acid is a long-acting bronchodilator that can be administered by inhalation. It has been used in the clinical development of medicines for the treatment of asthma and chronic obstructive pulmonary disease. 2-Hydroxy-2,2-bis(2-thienyl) acetic acid is chemically related to pyridinium compounds. It is a potent inhibitor of muscarinic receptors and has an anticholinergic profile similar to atropine. The safety profile of this drug seems to be favourable in humans with no major side effects reported so far.</p>Formula:C10H8O3S2Purity:Min. 95%Color and Shape:Yellow PowderMolecular weight:240.3 g/mol5-Methoxy-2-[[(3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole
CAS:<p>5-Methoxy-2-[[(3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole is a natural product. It is an impurity in the drug development process and may be present as an analytical marker for impurities. 5-Methoxy-2-[(3,5-dimethylpyridinium)methyl]sulfinyl]-1Hbenzimidazole is used as a pharmacopoeia standard and can be synthesized on request.</p>Formula:C16H17N3O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:315.39 g/mol5-Methoxy-2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole
CAS:<p>5-Methoxy-2-[(4-chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H benzimidazole is a synthetic drug product. It has been used as a positive control in metabolism studies and as an impurity standard. 5-Methoxy 2-[(4-chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfinyl]-5 methoxy 1H benzimidazole is also a metabolite of the active pharmaceutical ingredient (API) which is used to develop drugs. This chemical is synthesized by custom synthesis and can be obtained at high purity levels. The metabolite of this compound is 5 methoxy 2-[(4 chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfonyl]-5 methoxy 1H benzimidazole.</p>Formula:C16H16ClN3O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:349.84 g/molMethyl 2,2-dithienylglycolate
CAS:<p>Intermediate for tiotropium bromide synthesis</p>Formula:C11H10O3S2Purity:Min. 95%Color and Shape:White PowderMolecular weight:254.33 g/mol



